Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo-Reference-Cited by-同舟云学术

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

Published:2019-02 Issue: Volume:442 Page:91-103
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

De Vera Albert A.,Gupta Pranav,Lei Zining,Liao Dan,Narayanan Silpa,Teng Qiuxu,Reznik Sandra E.,Chen Zhe-Sheng^ORCID

Funder

NIH

St. John’s University Research Seed

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference63 articles.

1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2018

2. Two hundred years of cancer research;DeVita;N. Engl. J. Med.,2012

3. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein;Thomas;Cancer Control J. Moffitt Cancer Cent.,2003

4. Mechanisms and insights into drug resistance in cancer;Zahreddine;Front. Pharmacol.,2013

5. Multidrug resistance in cancer: role of ATP-dependent transporters;Gottesman;Nat. Rev. Canc.,2002

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature;Cancer Immunology, Immunotherapy;2024-08-06

2. Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles;International Journal of Molecular Sciences;2024-05-20

3. Targeting PI3K-gamma in myeloid driven tumour immune suppression: A Systematic Review and Meta-Analysis of the Preclinical Literature;2024-05-14

4. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling;Frontiers in Pharmacology;2024-01-10

5. Pemigatinib, a selective FGFR inhibitor overcomes ABCB1-mediated multidrug resistance in cancer cells;Biochemical and Biophysical Research Communications;2024-01